Amneal Pharmaceuticals

Amneal Pharmaceuticals is a global biopharmaceutical company that develops and manufactures complex generics, biosimilars, injectable medicines and specialty treatments. Founded in 2002 and headquartered in Bridgewater, New Jersey, the company has been in operation for more than two decades and manufactures over 290 pharmaceutical products. Its stated mission is to make essential medicines accessible to people who need them, not only to those who can afford them.

Its technical work spans complex generics, biosimilars, biosciences, injectable drug development and oncology therapeutics. The biosimilars programme is directed at lower-cost cancer treatments, while the injectable portfolio is intended to address persistent drug shortages. Specialty medicines cover complex health challenges, and pharmaceutical manufacturing underpins the wider portfolio.

Amneal has operations in the United States, India and Ireland. The company describes itself as founder-led: it was established by brothers Chirag and Chintu Patel, inspired by their father, Kanu Patel, an industrial pharmacist. It cites honesty and integrity in conducting business among its values, alongside an emphasis on taking on complex health problems directly.